港股異動 | 先聲藥業(2096.HK)漲超5% 料去年純利增約121%至130%

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

港股異動 | 先聲藥業(2096.HK)漲超5% 料去年純利增約121%至130%

格隆匯 02-23 14:14

格隆匯2月23日丨先聲藥業(2096.HK)股價繼續走強，現報9.48港元，漲幅5.45%，總市值250.3億港元，月內累計漲逾20%。公司21日公吿稱，預期截至2021年12月31日止年度所錄得的歸屬於公司權益股東的利潤約14.8億元至15.4億元人民幣，相比於去年同期歸屬於公司權益股東的利潤增加約8.1億至8.7億元人民幣，增幅約121%至130%。

先聲藥業(02096.HK)

Relevant Stocks

先聲藥業(02096.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

港股異動 | 先聲藥業(2096.HK)漲超5% 料去年純利增約121%至130%

Services

About Us

Agreement Statement